Articles & Research
from hVIVO

Isolation, Characterisation, GMP Production and First RSV-B Human Challenge Study

Incidental Myocarditis in Healthy Adults Following RSV Inoculation: Insights from a Decade of Controlled Human Infection Studies

Unravelling the hMPV Surge: From Media Attention to Vaccine Development

Inflammatory messaging It’s a confusing picture out there on what is really going on with hMPV infections globally currently. Since early January hMPV (or human metapneumovirus if we are to...

Scientific Paper

SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections

Madin-Darby Canine Kidney (MDCK) Cells: A Versatile Model in Virology and Biomedical Science

Madin-Darby Canine Kidney (MDCK) cells are a widely used cell line in biological and medical research, particularly in studies involving virology, cell biology, and membrane transport. Here’s an overview of...

Unlock Your RSV Research: How hVIVO’s RSV Strains & Human Challenge Models can Revolutionise your RSV Research

Virus portfolio: Respiratory Syncytial Virus RSV was first discovered in 1956. It was initially identified in chimpanzees by Dr. Robert Chanock and his colleagues while working at the National Institutes...

Vaccine and drug efficacy in viral challenge models: Use of patient perception questionnaires

Human viral challenge studies are generally developed to quickly test efficacy of vaccines, prophylactics and treatments in a relatively small number of participants compared to Phase 2a/b field studies. hVIVO...

Use of Multiplex PCR for eligibility screening of human challenge study participants and for new virus Isolation

We detail the use of multiplex qualitative PCR for 2 specific reasons. Firstly, on admission to our Clinical site to test for the presence of a panel of respiratory pathogens...

The Human Viral Challenge Model with A/PERTH/16/2009 H3N2 a systematic analysis from five clinical studies

The human viral challenge model is well established, safe and ideal to study influenza. It allows researchers to illuminate each step of the infection: baseline, peak and return to healthy....

State-of-the-art facilities contribute substantially to human clinical trial efficacy outcomes

Respiratory pathogens, such as the Influenza virus and Respiratory Syncytial Virus (RSV), remain a significant disease burden globally causing high levels of acute respiratory infections, morbidity and mortality. Human challenge...